ASX Announcement

Chimeric's Phase 1B glioblastoma trial presented at ASCO23

Published: 06/06/23, 11:03am (AEST)5 pages
Chimeric Therapeutics Limited
CHM:ASXHealthcare

Recent CHM Announcements

Price Sensitive only